
URSAchem
@ursachemlab
Org Chemistry lab focused on asymmetric catalysis and medicinal chemistry at @IRBBarcelona. Professors Antoni Riera and Xavier Verdaguer. Student run account.
ID: 739827836073193472
http://ursa.cat 06-06-2016 14:34:36
209 Tweet
302 Followers
212 Following


📢We are hiring! #PhDposition at Vall d’Hebron Institute of Oncology (VHIO) 🎯We aim to uncover novel patterns of chromosome instability in #cancer using 💻multi-omic analyses 🧬functional validations 💊to impact in patients My group▶️vhio.net/pf/sarcoma-tra… Apply▶️vhio.net/es/vhio-phd-op… Questions? DM or email!


A great day at the BIST-Barcelona Institute of Science and Technology Forum 2024! Congratulations to Dr. Antoni Riera and Dr. sara sdelci who presented their project EXPLODE-TNBC. This work aims to apply targeted protein degradation to find treatments for the elusive breast cancer type, Triple-Negative Breast cancer.

💊New drug reveals a key mechanism to overcome resistance to #ProteinDegraders. ✍️ Bárbara Barbosa Karen Sfyaki Ferran José Duran Sergi Rafael Cris Mayor-Ruiz URSAchem et al. 📰 Angewandte Chemie ➡️shorturl.at/gnFJY 📌doi.org/10.1002/anie.2… #IRBScience #TPD

🆕Chemical rewiring of ubiquitination by #degraders and their selectivity routes. ✍️Rory Whelan & Cris Mayor-Ruiz 📰🎂NatureStructMolBiol’s 3⃣0⃣th anniversary issue! 🔗shorturl.at/gmBIK 📌doi.org/10.1038/s41594… #IRBScience #TPD


En esta convocatoria de Cancer Grand Challenges Challenges, en Asociación Española Contra el Cáncer apoyamos a la Dra. Cris Mayor-Ruiz (IRB Barcelona) y su participación en el proyecto PROTECT para el desarrollo de tratamientos efectivos para cánceres infantiles. #investigandoencáncer ➡️contraelcancer.es/es/investigaci…


#IRBBarcelona scientist Cris Mayor-Ruiz to participate in the Cancer Grand Challenges team #PROTECT, to apply targeted protein degradation against various types of paediatric tumours. Asociación Española Contra el Cáncer is involved in this global funding initiative and supports this project, which will last



#PCBCommunity | Cris Mayor-Ruiz, group leader del laboratorio de Degradación Dirigida de Proteínas y Descubrimiento de Fármacos del IRB Barcelona, gana el Premio 60 Aniversario Farmaindustria Jóvenes Investigadores. ¡Felicidades! 👏🔝 Farmaindustria #cancer

Our PhD student Sergi Rafael presented his work at IRB Barcelona as part of the Research Nodes Seminar series. He explained his exciting research in Proximity-induced Pharmacology and its application toward developing novel treatments for evasive cancers. Well done Sergi!





Congrats to our PhD graduate Dr. Marina Bellido (Marina Bellido) and PhD student Marti Sidro (martichickpea) for their recent work in developing the p-stereogenic phosphane ligand, MAdPHOS, which provides outstanding enantioselectivities in asymmetric hydrogenation of enamides!


Another fascinating year of demonstrations by our group at the IRB Barcelona Open Day. Great to reach out to the community and show off the excitment of chemistry! Many thanks to IRB Barcelona for organising this fantastic event.
